Yoshikazu Uto

1.2k total citations
22 papers, 985 citations indexed

About

Yoshikazu Uto is a scholar working on Molecular Biology, Organic Chemistry and Surgery. According to data from OpenAlex, Yoshikazu Uto has authored 22 papers receiving a total of 985 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 8 papers in Organic Chemistry and 6 papers in Surgery. Recurrent topics in Yoshikazu Uto's work include Cholesterol and Lipid Metabolism (6 papers), Peroxisome Proliferator-Activated Receptors (6 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Yoshikazu Uto is often cited by papers focused on Cholesterol and Lipid Metabolism (6 papers), Peroxisome Proliferator-Activated Receptors (6 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Yoshikazu Uto collaborates with scholars based in Japan, Germany and United States. Yoshikazu Uto's co-authors include Peter Wipf, Michael J. Reno, David R. Williams, Andrew J. Phillips, Hyun Seung Ban, Hiroyuki Nakamura, Toshiyuki Takagi, Seiji Yoshimura, Jun Ohsumi and Yohei Kiyotsuka and has published in prestigious journals such as The Journal of Organic Chemistry, Chemistry - A European Journal and Organic Letters.

In The Last Decade

Yoshikazu Uto

22 papers receiving 965 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoshikazu Uto Japan 16 544 442 177 129 87 22 985
Michael H. Rabinowitz United States 17 545 1.0× 385 0.9× 256 1.4× 65 0.5× 73 0.8× 29 1.1k
Kyriacos C. Nicolaou United States 12 233 0.4× 392 0.9× 133 0.8× 97 0.8× 49 0.6× 17 833
Yunqing Lin China 11 427 0.8× 467 1.1× 202 1.1× 53 0.4× 60 0.7× 21 1.1k
Olesya A. Ulanovskaya United States 15 233 0.4× 636 1.4× 139 0.8× 67 0.5× 61 0.7× 18 925
James J.‐W. Duan United States 24 729 1.3× 521 1.2× 154 0.9× 144 1.1× 127 1.5× 46 1.4k
Susan Cornell-Kennon United States 12 223 0.4× 707 1.6× 304 1.7× 103 0.8× 138 1.6× 21 1.1k
Nicholas D. Adams United States 8 298 0.5× 416 0.9× 307 1.7× 41 0.3× 47 0.5× 11 817
Thomas Harrity United States 17 257 0.5× 611 1.4× 107 0.6× 103 0.8× 31 0.4× 23 1.1k
Mitsuaki Ohtani Japan 21 779 1.4× 536 1.2× 214 1.2× 307 2.4× 61 0.7× 40 1.5k
Raju Mohan United States 19 579 1.1× 647 1.5× 71 0.4× 70 0.5× 34 0.4× 35 1.3k

Countries citing papers authored by Yoshikazu Uto

Since Specialization
Citations

This map shows the geographic impact of Yoshikazu Uto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshikazu Uto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshikazu Uto more than expected).

Fields of papers citing papers by Yoshikazu Uto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshikazu Uto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshikazu Uto. The network helps show where Yoshikazu Uto may publish in the future.

Co-authorship network of co-authors of Yoshikazu Uto

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshikazu Uto. A scholar is included among the top collaborators of Yoshikazu Uto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshikazu Uto. Yoshikazu Uto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ban, Hyun Seung, Yoshikazu Uto, & Hiroyuki Nakamura. (2021). Hypoxia-inducible factor (HIF) inhibitors: a patent survey (2016–2020). Expert Opinion on Therapeutic Patents. 31(5). 387–397. 26 indexed citations
2.
Ban, Hyun Seung, Yoshikazu Uto, Misun Won, & Hiroyuki Nakamura. (2016). Hypoxia-inducible factor (HIF) inhibitors: a patent survey (2011-2015). Expert Opinion on Therapeutic Patents. 26(3). 309–322. 42 indexed citations
3.
Uto, Yoshikazu. (2015). Recent progress in the discovery and development of stearoyl CoA desaturase inhibitors. Chemistry and Physics of Lipids. 197. 3–12. 56 indexed citations
4.
Uto, Yoshikazu. (2015). 1,2-Benzisoxazole compounds: a patent review (2009 – 2014). Expert Opinion on Therapeutic Patents. 25(6). 643–662. 11 indexed citations
5.
Uto, Yoshikazu. (2014). Imidazo[1,2-a]pyridines as cholesterol 24-hydroxylase (CYP46A1) inhibitors: a patent evaluation (WO2014061676). Expert Opinion on Therapeutic Patents. 25(3). 373–377. 5 indexed citations
6.
Kurikawa, Nobuya, et al.. (2013). A Novel Inhibitor of Stearoyl-CoA Desaturase-1 Attenuates Hepatic Lipid Accumulation, Liver Injury and Inflammation in Model of Nonalcoholic Steatohepatitis. Biological and Pharmaceutical Bulletin. 36(2). 259–267. 34 indexed citations
7.
Uto, Yoshikazu. (2012). Benzisoxazole analogs as glycogen synthase activators, a patent evaluation (WO2011057956). Expert Opinion on Therapeutic Patents. 22(6). 701–707. 1 indexed citations
8.
Uto, Yoshikazu. (2012). Piperidine and pyrrolidine analogs as glycogen synthase activators; a patent evaluation (WO2011058122). Expert Opinion on Therapeutic Patents. 22(1). 89–93. 4 indexed citations
9.
Ban, Hyun Seung, Yoshikazu Uto, & Hiroyuki Nakamura. (2011). Hypoxia-inducible factor inhibitors: a survey of recent patented compounds (2004 – 2010). Expert Opinion on Therapeutic Patents. 21(2). 131–146. 39 indexed citations
10.
Uto, Yoshikazu, Yuko Ueno, Yohei Kiyotsuka, et al.. (2011). Discovery of novel SCD1 inhibitors: 5-Alkyl-4,5-dihydro-3H-spiro[1,5-benzoxazepine-2,4′-piperidine] analogs. European Journal of Medicinal Chemistry. 46(5). 1892–1896. 18 indexed citations
11.
Uto, Yoshikazu, Yuko Ueno, Yohei Kiyotsuka, et al.. (2010). Synthesis and evaluation of novel stearoyl-CoA desaturase 1 inhibitors: 1′-{6-[5-(pyridin-3-ylmethyl)-1,3,4-oxadiazol-2-yl]pyridazin-3-yl}-3,4-dihydrospiro[chromene-2,4′-piperidine] analogs. European Journal of Medicinal Chemistry. 45(11). 4788–4796. 27 indexed citations
12.
Uto, Yoshikazu, Jun Harada, Yohei Kiyotsuka, et al.. (2009). Novel and potent inhibitors of stearoyl-CoA desaturase-1. Part I: Discovery of 3-(2-hydroxyethoxy)-4-methoxy-N-[5-(3-trifluoromethylbenzyl)thiazol-2-yl]benzamide. Bioorganic & Medicinal Chemistry Letters. 19(15). 4151–4158. 20 indexed citations
13.
14.
Uto, Yoshikazu, Yohei Kiyotsuka, Yuko Ueno, et al.. (2009). Novel and potent inhibitors of stearoyl-CoA desaturase-1. Part II: Identification of 4-ethylamino-3-(2-hydroxyethoxy)-N-[5-(3-trifluoromethylbenzyl)thiazol-2-yl]benzamide and its biological evaluation. Bioorganic & Medicinal Chemistry Letters. 19(15). 4159–4166. 26 indexed citations
15.
16.
Miyoshi, Anderson, Yoshihiko Kitajima, Takao Ide, et al.. (2006). Hypoxia accelerates cancer invasion of hepatoma cells by upregulating MMP expression in an HIF-1α-independent manner. International Journal of Oncology. 29(6). 1533–9. 53 indexed citations
17.
Wipf, Peter, Yoshikazu Uto, & Seiji Yoshimura. (2002). Total Synthesis of a Stereoisomer of Bistramide C and Assignment of Configuration of the Natural Product. Chemistry - A European Journal. 8(7). 1670–1681. 39 indexed citations
18.
Phillips, A.J., et al.. (2002). Synthesis of Functionalized Oxazolines and Oxazoles with DAST and Deoxo-Fluor. Organic Letters. 4(26). 4743–4743. 5 indexed citations
19.
Phillips, Andrew J., Yoshikazu Uto, Peter Wipf, Michael J. Reno, & David R. Williams. (2000). Synthesis of Functionalized Oxazolines and Oxazoles with DAST and Deoxo-Fluor. Organic Letters. 2(8). 1165–1168. 400 indexed citations
20.
Wipf, Peter & Yoshikazu Uto. (1999). Total synthesis of the putative structure of the marine metabolite trunkamide A. Tetrahedron Letters. 40(28). 5165–5169. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael H. Rabinowitz Breakdown of academic impact, for papers by Kyriacos C. Nicolaou Breakdown of academic impact, for papers by Yunqing Lin Breakdown of academic impact, for papers by Olesya A. Ulanovskaya Breakdown of academic impact, for papers by James J.‐W. Duan Breakdown of academic impact, for papers by Susan Cornell-Kennon Breakdown of academic impact, for papers by Nicholas D. Adams Breakdown of academic impact, for papers by Thomas Harrity Breakdown of academic impact, for papers by Mitsuaki Ohtani Breakdown of academic impact, for papers by Raju Mohan
Rankless by CCL
2026